Oragenics (OGEN) Operating Margin (QoQ) (2010 - 2023)
Oragenics (OGEN) Operating Margin (QoQ) (2010 - 2023) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Oragenics | 2.32 Mn | 2.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -443,147.00 |
| Jun 30, 2023 | -655,859.00 |
| Sep 30, 2022 | 732,032.00 |
| Jun 30, 2022 | 1.87 Mn |
| Dec 31, 2014 | -4,307.00 |
| Sep 30, 2014 | 11,151.00 |
| Jun 30, 2014 | 14,183.00 |
| Mar 31, 2014 | -6,130.00 |
| Dec 31, 2013 | 297,364.00 |
| Sep 30, 2013 | -244,279.00 |
| Jun 30, 2013 | -25,357.00 |
| Mar 31, 2013 | -52,242.00 |
| Dec 31, 2012 | 33,167.00 |
| Sep 30, 2012 | 188,542.00 |
| Jun 30, 2012 | -229,019.00 |
| Mar 31, 2012 | 6,914.00 |
| Dec 31, 2011 | 3,062.00 |
| Sep 30, 2011 | 17,460.00 |
| Jun 30, 2011 | -22,995.00 |
| Mar 31, 2011 | 32,979.00 |